Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 1.36 | $ 176.71M | 1 | 129.73M |
3/31/2025 | $ 1.62 | $ 210.2M | 1 | 129.68M |
12/31/2024 | $ 2.15 | $ 240.97M | 1 | 111.99M |
9/30/2024 | $ 1.93 | $ 229.09M | 1 | 118.7M |
6/30/2024 | $ 2.25 | $ 255.22M | 1 | 113.43M |
3/31/2024 | $ 1.3 | $ 122.97M | 1 | 94.88M |
12/31/2023 | $ 2.3 | $ 150.87M | 1 | 65.6M |
9/30/2023 | $ 1.78 | $ 168.96M | 1 | 94.83M |
6/30/2023 | $ 4.04 | $ 190.61M | 1 | 47.21M |
3/31/2023 | $ 3.22 | $ 78.02M | 1 | 24.23M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for TSCAN THERAPEUTICS INC is calculated as follows: Equity [ $ -42.46M ] / (Shares WA [ 916.01K ] * Share Factor [ 1 ])
(=) BVPS [ $ -46.36 ]
Minimum
Dec 31, 2020
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.99K |
---|---|
min | $ -30.1 |
max | $ 46.62 |
average | $ 10.29 |
median | $ 6.08 |
std | $ 12.44 |